Previous studies confirmed that in breast cancer, tumor-induced Bregs promote tumor metastasis by converting dormant CD4+CD25− T cells into CD4+CD25+Foxp3+ Tregs, while in the absence of tumor-induced Bregs, the conversion of Tregs was significantly reduced and tumor metastasis was blocked [17]. This evidence concerns the gene FOXP3 and breast cancer.